8-K
Aeluma, Inc. (ALMU)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the SecuritiesExchange Act of 1934
Date of Report (Date of earliest event reported):May 7, 2025
Aeluma, Inc.
(Exact name of registrant as specified in itscharter)
| Delaware | 001-42570 | 85-2807351 |
|---|---|---|
| (State or other jurisdictionof incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
| 27 Castilian Drive Goleta, California | 93117 | |
| --- | --- | |
| (Address of principal executive offices) | (Zip Code) |
805-351-2707
(Registrant’s telephone number, includingarea code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ☐ | Written<br>communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|---|---|
| ☐ | Soliciting<br>material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| --- | --- |
| ☐ | Pre-commencement<br>communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| --- | --- |
| ☐ | Pre-commencement<br>communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| --- | --- |
Securities registered pursuant to Section 12(b) of the Act: none.
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and FinancialCondition.
On May 7, 2025, Aeluma, Inc. (the “Company”) issued a press release announcing its financial results for the third quarter ended March 31, 2025. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
The information reported under this Item 2.02 of Form 8-K, including Exhibit 99.1, is being furnished and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of such section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
| Exhibit Number | Exhibit |
|---|---|
| 99.1 | Press Release of Aeluma, Inc. dated May 7, 2025 |
| 104 | Cover<br> Page Interactive Data File (embedded within the Inline XBRL document) |
1
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| AELUMA, INC. | ||
|---|---|---|
| Date: May 7, 2025 | By: | /s/ Jonathan Klamkin |
| Jonathan Klamkin | ||
| President, Chief Executive Officer and Director |
2
Exhibit 99.1
Aeluma Provides Third Quarter of Fiscal Year2025 Results
Reports Record Third Quarter with RevenueGrowth of 265%
Momentum Builds with NASDAQ Uplisting, StrongCapital Position, and Growing Demand Across AI and Defense
GOLETA, CA – May 7, 2025 – **** Aeluma, Inc. (NASDAQ:ALMU), a semiconductor company specializing in high-performance, scalable technologies for mobile, automotive, AI, defense and aerospace, communication, and quantum computing, today provided a corporate update and announced financial results for the third quarter of fiscal 2025, which ended March 31, 2025.
Recent Company Highlights
| ● | NASDAQ Uplist and Capital Raise: Closed oversubscribed public offering with $13.8 million gross proceeds, bringing total capital<br>raised in fiscal year to nearly $17 million. Completed uplist to NASDAQ under ticker “ALMU.” |
|---|---|
| ● | Board Expansion: Appointed former NVIDIA finance leader Mike Byron to the Board of Directors, strengthening strategic leadership<br>to help scale operations for AI and quantum computing markets. |
| --- | --- |
| ● | U.S. Department of Energy Contract: Secured funding to accelerate development of low-cost shortwave infrared photodetectors<br>applicable to mobile, AR/VR, and industrial markets. |
| --- | --- |
| ● | SPIE Defense + Commercial Sensing: Showcased next-generation photonic solutions for scaling sensing, 3D imaging, and silicon<br>photonics at Exhibition. Presented technical talks and participated in an industry panel on “Silicon Photonics for Defense and National<br>Security.” |
| --- | --- |
| ● | NSTC Membership: Became a member of the National Semiconductor Technology Center (NSTC), a CHIPS Act initiative aimed at strengthening<br>U.S. leadership in semiconductor technology, manufacturing, and supply chain resilience. |
| --- | --- |
| ● | Optical Fiber Communications (OFC) Conference Presentation: Joint research presented with AIM Photonics and UC Santa Barbara<br>on quantum dot lasers integrated with silicon photonics for AI and co-packaged optics. |
| --- | --- |
| ● | Laser Focus World Feature: Highlighted in a technical feature outlining how scalable quantum dot lasers are key for optical<br>interconnects in AI infrastructure. |
| --- | --- |
| ● | Media Visibility: CEO Jonathan Klamkin featured in SemiWiki’s CEO interview series, discussing Aeluma’s mission,<br>commercial roadmap, and government engagements. |
| --- | --- |
Management Commentary
“We believe that the combination of our successful uplist to NASDAQ, our oversubscribed capital raise, our third-quarter revenue, and our strong revenue backlog poises Aeluma for a strong growth trajectory,” said Jonathan Klamkin, Ph.D., Founder and CEO of Aeluma. “Commercial interest in our technology across defense and aerospace, AI infrastructure, consumer sensing, quantum computing, and automotive continues to grow. Aeluma should be in a position to transition to commercialization to support the demands of several of these high-growth markets in the near future.”
1
Financial Results
For the quarter ended March 31, 2025, revenue was $1.3 million, compared to $344 thousand in the same quarter last year, and $1.6 million in the prior quarter.
The company recorded a net income of $1.5 million, or $0.12 and $0.11, respectively per basic and diluted share, for the quarter ended March 31, 2025, compared to a net loss of $963 thousand, or ($0.08) per basic and diluted share, for the same quarter last year, and a net loss of $2.9 million, or ($0.24) per basic and diluted share, in the prior quarter. Net income varied quarter-over-quarter primarily due to non-cash changes in fair value of derivative liabilities of $2.6 million gain in the quarter ended March 31, 2025 following the $3.0 million loss in the prior quarter. Non-GAAP net income was $7 thousand for the quarter ended March 31, 2025.
Adjusted EBITDA for the quarter ended March 31, 2025 was $109 thousand, compared to ($685) thousand for the same quarter last year, and $648 thousand in the prior quarter.
The Company had $15.9 million in cash and cash equivalents, and certificate of deposit as of March 31, 2025, compared to $3.1 million as of December 31, 2024 and $1.9 million as of March 31, 2024.
The total number of shares outstanding was 15,795,467 as of March 31, 2025.
Revenue Guidance
Aeluma met its revenue target for the quarter and is tracking to meet its annual revenue guidance of approximately $4.4-4.6 million for fiscal 2025. Aeluma continues to build confidence in its growth trajectory, supported by strong contract performance and expanding market opportunities.
These statements are forward looking and actual results may differ materially. Refer to the Forward-Looking Statements section below for information on the factors that could cause our actual results to differ materially from these forward-looking statements.
Note about Non-GAAP Financial Measures
This press release includes and makes reference to certain non-GAAP financial measures. The presentation of this financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP. Aeluma believes that the presentation of non-GAAP financial measures provides important supplemental information to management and investors regarding financial and business trends relating to the Company’s financial condition and results of operations. Aeluma believes that these non-GAAP financial measures provide additional insight into Aeluma’s ongoing performance and core operational activities and has chosen to provide these measures for more consistent and meaningful comparison between periods. These measures should only be used to evaluate Aeluma’s results of operations in conjunction with the corresponding GAAP measures. The non-GAAP results exclude the effect of stock-based compensation, depreciation and amortization.
This press release includes non-GAAP financial measures, including:
| ● | Non-GAAP net income (loss), which is defined as GAAP net income (loss) plus stock-based compensation expenses, amortization of discount<br>on convertible notes, and changes in fair value of derivative liabilities; and |
|---|---|
| ● | Adjusted EBITDA, defined as non-GAAP net income (loss) plus depreciation and amortization expenses, less interest income. |
| --- | --- |
A reconciliation between GAAP and non-GAAP financial results is provided in the financial statements portion of this press release.
2
About Aeluma, Inc.
Aeluma (www.aeluma.com) develops photonics and optoelectronics for sensing, computing, and communication applications. Aeluma has pioneered a technique to manufacture semiconductor chips using high-performance compound semiconductor materials on large-diameter substrates that are commonly used for mass-market microelectronics. The technology has the potential to enhance performance and scale manufacturing, both of which are critical for emerging applications. Aeluma is developing a streamlined business model from its headquarters in Santa Barbara, California that has a state-of-the-art manufacturing cleanroom. Its transformative semiconductor chip technology may impact a variety of markets including mobile, defense and aerospace, AI, automotive, AR/VR, quantum, and communication. Aeluma differentiates itself with unique semiconductor manufacturing capability, proprietary technology, the ability to perform rapid prototyping, and a broad set of product offerings.
Forward-Looking Statements
All statements in this press release that are not historical are forward-looking statements, including, among other things, statements relating to the Company’s expectations regarding its market position and market opportunity, expectations and plans as to its product development, manufacturing and sales, and relations with its partners and investors. These statements are not historical facts but rather are based on the Company’s current expectations, estimates, and projections regarding its business, operations and other similar or related factors. Words such as “may,” “will,” “could,” “would,” “should,” “anticipate,” “predict,” “potential,” “continue,” “expect,” “intend,” “plan,” “project,” “believe,” “estimate,” and other similar or related expressions are used to identify these forward-looking statements, although not all forward-looking statements contain these words. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties, and assumptions that are difficult or impossible to predict and, in some cases, beyond the Company’s control. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described in the Company’s filings with the Securities and Exchange Commission. The Company undertakes no obligation to revise or update information in this release to reflect events or circumstances in the future, even if new information becomes available.
Company
Aeluma, Inc.
(805) 351-2707
info@aeluma.com
Investor Contact
Bishop IR
Mike Bishop
(415) 894-9633
ir@aeluma.com
3
Aeluma, Inc. and Subsidiary
Consolidated Balance Sheets (unaudited)
| March 31,<br> 2025 | December 31,<br> 2024 | June 30, <br> 2024 | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Current assets: | |||||||||
| Cash and cash equivalents | $ | 3,865,659 | $ | 3,063,059 | $ | 1,291,072 | |||
| Certificate of deposit | 12,000,000 | - | - | ||||||
| Accounts receivable | 1,143,417 | 1,324,632 | 60,004 | ||||||
| Deferred compensation, current portion | 3,086 | 6,171 | 20,133 | ||||||
| Prepaids and other current assets | 213,833 | 136,307 | 21,637 | ||||||
| Total current assets | 17,225,995 | 4,530,169 | 1,392,846 | ||||||
| Property and equipment: | |||||||||
| Equipment | 1,616,669 | 1,572,291 | 1,531,494 | ||||||
| Leasehold improvements | 546,864 | 546,864 | 546,864 | ||||||
| Accumulated depreciation | (913,530 | ) | (809,436 | ) | (608,630 | ) | |||
| Property and equipment, net | 1,250,003 | 1,309,719 | 1,469,728 | ||||||
| Intangible assets | 4,583 | 5,333 | 6,833 | ||||||
| Right of use asset - facility | 868,145 | 899,623 | 961,626 | ||||||
| Other assets | 13,014 | 13,014 | 13,014 | ||||||
| Total assets | $ | 19,361,740 | $ | 6,757,858 | $ | 3,844,047 | |||
| Liabilities and stockholders’ equity | |||||||||
| Current liabilities: | |||||||||
| Accounts payable | $ | 173,207 | $ | 182,932 | $ | 317,237 | |||
| Accrued expenses and other current liabilities | 216,782 | 172,414 | 180,706 | ||||||
| Lease liability, current portion | 135,854 | 133,460 | 128,743 | ||||||
| Total current liabilities | 525,843 | 488,806 | 626,686 | ||||||
| Lease liability, long-term portion | 838,802 | 873,276 | 941,200 | ||||||
| Derivative liabilities | - | 5,048,174 | - | ||||||
| Convertible notes, net | - | 1,379,690 | - | ||||||
| Total liabilities | 1,364,645 | 7,789,946 | 1,567,886 | ||||||
| Commitments and contingencies | - | - | - | ||||||
| Stockholders’ equity (deficit): | |||||||||
| Preferred stock | - | - | - | ||||||
| Common stock | 1,579 | 1,224 | 1,218 | ||||||
| Additional paid-in capital | 33,783,427 | 16,215,492 | 15,899,304 | ||||||
| Accumulated deficit | (15,787,911 | ) | (17,248,804 | ) | (13,624,361 | ) | |||
| Total stockholders’ equity (deficit) | 17,997,095 | (1,032,088 | ) | 2,276,161 | |||||
| Total liabilities and stockholders’ equity | $ | 19,361,740 | $ | 6,757,858 | $ | 3,844,047 |
4
Aeluma, Inc. and Subsidiary
Consolidated Statements of Operations (unaudited)
| Three Months Ended | Nine Months Ended | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 31, <br><br>2025 | December 31,<br><br> 2024 | March 31, <br><br>2024 | March 31, <br><br>2025 | March 31, <br><br>2024 | |||||||||||
| Revenue | $ | 1,254,966 | $ | 1,612,519 | $ | 343,894 | $ | 3,348,220 | $ | 639,286 | |||||
| Operating expenses: | |||||||||||||||
| Cost of revenue | 413,085 | 584,549 | 233,585 | 1,312,209 | 385,491 | ||||||||||
| Research and development | 470,979 | 268,061 | 620,285 | 1,140,114 | 2,106,253 | ||||||||||
| General and administrative | 1,202,372 | 370,311 | 452,792 | 2,069,149 | 1,721,820 | ||||||||||
| Total expenses | 2,086,436 | 1,222,921 | 1,306,662 | 4,521,472 | 4,213,564 | ||||||||||
| Income (loss) from operations | (831,470 | ) | 389,598 | (962,768 | ) | (1,173,252 | ) | (3,574,278 | ) | ||||||
| Other income (expense): | |||||||||||||||
| Interest income | 2,558 | 101 | 198 | 2,761 | 879 | ||||||||||
| Other expense | - | - | (81 | ) | - | (81 | ) | ||||||||
| Amortization of discount on convertible notes | (287,298 | ) | (283,043 | ) | - | (715,117 | ) | - | |||||||
| Changes in fair value of derivative liabilities | 2,577,103 | (3,001,480 | ) | - | (277,942 | ) | - | ||||||||
| Total other income (expense), net | 2,292,363 | (3,284,422 | ) | 117 | (990,298 | ) | 798 | ||||||||
| Income (loss) before income tax expense | 1,460,893 | (2,894,824 | ) | (962,651 | ) | (2,163,550 | ) | (3,573,480 | ) | ||||||
| Income tax expense | - | - | - | - | - | ||||||||||
| Net income (loss) | $ | 1,460,893 | $ | (2,894,824 | ) | $ | (962,651 | ) | $ | (2,163,550 | ) | $ | (3,573,480 | ) | |
| Net income (loss) per share: | |||||||||||||||
| Basic | $ | 0.12 | $ | (0.24 | ) | $ | (0.08 | ) | $ | (0.18 | ) | $ | (0.29 | ) | |
| Diluted | $ | 0.11 | $ | (0.24 | ) | $ | (0.08 | ) | $ | (0.18 | ) | $ | (0.29 | ) | |
| Weighted average common shares outstanding: | |||||||||||||||
| Basic | 12,472,061 | 12,212,403 | 12,175,195 | 12,286,284 | 12,338,041 | ||||||||||
| Diluted | 13,206,919 | 12,212,403 | 12,175,195 | 12,286,284 | 12,338,041 | ||||||||||
| Book value per share | $ | 1.44 | $ | (0.08 | ) | $ | 0.19 | $ | 1.44 | $ | 0.19 |
5
Aeluma, Inc. and Subsidiary
Reconciliation of GAAP and Non-GAAP Financial Measures (unaudited)
| Three Months Ended | Nine Months Ended | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 31, <br> 2025 | December 31, <br> 2024 | March 31, <br> 2024 | March 31, <br> 2025 | March 31,<br> 2024 | |||||||||||
| GAAP net income (loss) | $ | 1,460,893 | $ | (2,894,824 | ) | $ | (962,651 | ) | $ | (2,163,550 | ) | $ | (3,573,480 | ) | |
| Non-GAAP adjustments: | |||||||||||||||
| Stock-based compensation - stock option | 832,792 | 149,103 | 191,844 | 1,148,986 | 568,340 | ||||||||||
| Consulting and advisory - restricted stock award | 3,085 | 6,981 | 6,981 | 17,047 | 25,920 | ||||||||||
| Amortization of discount on convertible notes | 287,298 | 283,043 | - | 715,117 | - | ||||||||||
| Changes in fair value of derivative liabilities | (2,577,103 | ) | 3,001,480 | - | 277,942 | - | |||||||||
| Total adjustments to GAAP net income (loss) | (1,453,928 | ) | 3,440,607 | 198,825 | 2,159,092 | 594,260 | |||||||||
| Non-GAAP net income (loss) | $ | 6,965 | $ | 545,783 | $ | (763,826 | ) | $ | (4,458 | ) | $ | (2,979,220 | ) | ||
| Depreciation & amortization | 104,845 | 102,181 | 78,663 | 307,150 | 211,196 | ||||||||||
| Interest income | (2,558 | ) | (101 | ) | 198 | (2,761 | ) | 879 | |||||||
| Adjusted EBITDA | $ | 109,252 | $ | 647,863 | $ | (684,965 | ) | $ | 299,931 | $ | (2,767,145 | ) | |||
| GAAP net income (loss) per share - basic | $ | 0.12 | $ | (0.24 | ) | $ | (0.08 | ) | $ | (0.18 | ) | $ | (0.29 | ) | |
| Non-GAAP adjustments | (0.12 | ) | 0.28 | 0.02 | 0.18 | 0.05 | |||||||||
| Non-GAAP net income (loss) per share - basic | $ | - | $ | 0.04 | $ | (0.06 | ) | $ | - | $ | (0.24 | ) | |||
| GAAP net income (loss) per share - diluted | $ | 0.11 | $ | (0.24 | ) | $ | (0.08 | ) | $ | (0.18 | ) | $ | (0.29 | ) | |
| Non-GAAP adjustments | (0.11 | ) | 0.28 | 0.02 | 0.18 | 0.05 | |||||||||
| Non-GAAP net income (loss) per share - diluted | $ | - | $ | 0.04 | $ | (0.06 | ) | $ | - | $ | (0.24 | ) |
6
Aeluma, Inc. and Subsidiary
Consolidated Statements of Cash Flows (unaudited)
| Nine Months Ended<br><br> March 31, | ||||||
|---|---|---|---|---|---|---|
| 2025 | 2024 | |||||
| Operating activities: | ||||||
| Net loss | $ | (2,163,550 | ) | $ | (3,573,480 | ) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||||
| Amortization of deferred compensation | 17,047 | 25,920 | ||||
| Stock-based compensation expense | 1,148,986 | 568,340 | ||||
| Depreciation and amortization expense | 307,150 | 211,196 | ||||
| Amortization of discount on convertible notes | 715,117 | - | ||||
| Changes in fair value of derivative liabilities | 277,942 | - | ||||
| Changes in operating assets and liabilities: | ||||||
| Accounts receivable | (1,083,413 | ) | 41,739 | |||
| Prepaids and other current assets | (192,196 | ) | (76,170 | ) | ||
| Accounts payable | (144,030 | ) | (114,561 | ) | ||
| Accrued expenses and other current liabilities | 34,270 | 40,826 | ||||
| Net cash used in operating activities | (1,082,677 | ) | (2,876,190 | ) | ||
| Investing activities: | ||||||
| Purchase of equipment | (85,175 | ) | (316,934 | ) | ||
| Net cash used in investing activities | (85,175 | ) | (316,934 | ) | ||
| Financing activities: | ||||||
| Repurchase of common stock | - | (4,001 | ) | |||
| Proceed from stock option exercise | 10,000 | - | ||||
| Proceeds from convertible notes issuance | 3,145,000 | - | ||||
| Proceeds from Public Offering, net of costs | 12,587,439 | - | ||||
| Net cash provided by (used in) financing activities | 15,742,439 | (4,001 | ) | |||
| Net change in cash and cash equivalent, and certificate of deposit | 14,574,587 | (3,197,125 | ) | |||
| Cash and cash equivalent, and certificate of deposit, beginning of period | 1,291,072 | 5,071,690 | ||||
| Cash and cash equivalent, and certificate of deposit, end of period | $ | 15,865,659 | $ | 1,874,565 | ||
| Supplemental non-cash disclosures: | ||||||
| Conversion of convertible notes to stockholders’ equity | $ | 1,666,988 | - | |||
| Conversion of derivative liabilities to stockholders’ equity | $ | 2,471,071 | - |
7